Connecticut passed a new law last week in an effort to lower its spending on weight-loss drugs for its state insurance ...

Thrive Health Solutions also faces a lawsuit from drugmaker Eli Lilly, for allegedly making false claims about FDA approval when selling compounded version of tirzepatide.

According to a new feature by the Washington Post, approximately 16 million American adults are on GLP-1 drugs such as ...

NVO shares fall 19.9% year to date amid weak CagriSema data, CEO exit and rising pressure from rivals in obesity care.

Hengrui has reported topline data from the 301 study of their dual GLP-1 and GIP agonist HRS9531, administered as a ...

There’s a perception that Ozempic, Wegovy and Zepbound are all you need to live a healthier life. But diet and exercise still ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The ...

Weight loss injections can help people lose more weight than with other methods of weight loss, including lifestyle changes ...

While severe climate-related disasters were linked with decreased access to health care infrastructure, moderate climate-related disasters were linked with increased access and redevelopment. In other ...

Key Takeaways Menopause hormone therapy appears to boost the effectiveness of tirzepatide (Zepbound)Women lost more weight ...

A new study suggests that eating more protein while taking GLP-1 medications could help prevent muscle loss, a common side ...

New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next ...